Latest filing published 12 Aug 2026 for Hepion Pharmaceuticals, Inc., €87k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 30 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -16.4%Entry US$15.90 · Close at T+365 US$13.30
- -15.7%Entry US$14.50 · Close at T+365 US$12.23
- +13.4%Entry US$12.70 · Close at T+365 US$14.40
- -4.5%Entry US$15.50 · Close at T+365 US$14.80
- +11.4%Entry US$13.20 · Close at T+365 US$14.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gary S. Stetz: trading record in brief
Gary S. Stetz discloses dealings in 3 companies, chiefly BCB Bancorp Inc, Canton Strategic Holdings, Inc. and Hepion Pharmaceuticals, Inc. We count 40 filings; the first trade dates from 18 May 2012 and the latest from 3 August 2026.
Market trades split into 32 purchases (€372k) and 8 sales (€296k). The net balance comes to €76k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 2 purchases and 8 sales.
Half of the purchases are above €4,356 and half below. 5 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 30 purchases show a median change of +4.2%, with the price up in 80% of them. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 12 August 2026 with an open-market purchase (€87k) in Hepion Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gary S. Stetz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ US$0.051.74% mcap67.1% of flowCommon StockSEC:0001493152-26-037496:0Canonical exit: 1 Nov 2026 (T+90)
- 10,000 shares@ US$3.4513.4% of flowCommon StockSEC:0001493152-26-025469:0
- 15,000 shares@ US$3.4019.8% of flowCommon StockSEC:0001493152-26-025469:2
- 15,000 shares@ US$3.4119.8% of flowCommon StockSEC:0001493152-26-025469:3
- 10,000 shares@ US$3.4013.2% of flowCommon StockSEC:0001493152-26-025469:5
- 12,851 shares@ US$3.4417.1% of flowCommon StockSEC:0001493152-26-025469:6
- 12,500 shares@ US$3.4716.8% of flowCommon StockSEC:0001493152-26-025469:7
- 1,250,000 shares@ US$0.040.74% mcap32.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001493152-26-019027:0Canonical exit: 20 Jul 2026 (T+90)
- 500 shares@ US$15.804.3% of flowCommon StockSEC:0001140361-18-013417:0Canonical exit: 12 Jun 2018 (T+90)
- 1,500 shares@ US$14.6012.4% of flowCommon StockSEC:0001140361-17-039542:0Canonical exit: 23 Jan 2018 (T+90)
- 250 shares@ US$14.502.0% of flowCommon StockSEC:0001140361-17-039542:1Canonical exit: 23 Jan 2018 (T+90)
- 10,000 shares@ US$12.2568.3% of flowCommon StockSEC:0001140361-17-035554:0Canonical exit: 11 Dec 2017 (T+90)
- 250 shares@ US$15.502.3% of flowCommon StockSEC:0001140361-17-025585:0Canonical exit: 18 Sept 2017 (T+90)
- 725 shares@ US$12.946.0% of flowCommon StockSEC:0001140361-16-090211:0Canonical exit: 15 Mar 2017 (T+90)
- 600 shares@ US$9.953.6% of flowCommon StockSEC:0001140361-16-055413:0Canonical exit: 25 May 2016 (T+90)
- 200 shares@ US$9.831.2% of flowCommon StockSEC:0001140361-16-055413:1Canonical exit: 26 May 2016 (T+90)
- 1,000 shares@ US$13.04Common StockSEC:0001140361-14-034147:0Canonical exit: 23 Nov 2014 (T+90)
- 1,000 shares@ US$13.20Common StockSEC:0001140361-14-019773:0Canonical exit: 6 Aug 2014 (T+90)
- 400 shares@ US$13.18Common StockSEC:0001140361-14-017529:0Canonical exit: 23 Jul 2014 (T+90)
- 100 shares@ US$13.32Common StockSEC:0001140361-14-004699:0Canonical exit: 4 May 2014 (T+90)
- 300 shares@ US$13.11Common StockSEC:0001140361-14-004699:1Canonical exit: 4 May 2014 (T+90)
- 835 shares@ US$12.00Common StockSEC:0001140361-14-001356:0Canonical exit: 17 Mar 2014 (T+90)
- 200 shares@ US$13.42Common StockSEC:0001140361-13-045588:0Canonical exit: 10 Mar 2014 (T+90)
- 600 shares@ US$13.80Common StockSEC:0001140361-13-045588:1Canonical exit: 10 Mar 2014 (T+90)
- 200 shares@ US$13.91Common StockSEC:0001140361-13-045588:2Canonical exit: 10 Mar 2014 (T+90)
25 of 36 declarations